ROIV - Roivant Sciences Ltd.

QQQ $ 479.35 $ 5.42 (1.14 %)

DIA $ 391.06 $ -2.96 (-0.75 %)

SPY $ 544.78 $ 2.09 (0.39 %)

TLT $ 94.49 $ 0.16 (0.17 %)

GLD $ 214.55 $ -1.07 (-0.5 %)

Previous Close

$ 10.83

Open

$ 10.83

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 10.74 - $ 11.02

52 Week Range

$ 8.25 - $ 13.24

Volume

4,397,449

Average Volume

Market Cap

9.15B

Beta (5Y Monthly)

$ 0.86

PE Ratio (TTM)

$ 1.98

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-30-2024	03-31-2024	10-K
2	02-13-2024	12-31-2023	10-Q
3	11-13-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	06-28-2023	03-31-2023	10-K
6	02-13-2023	12-31-2022	10-Q
7	11-14-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	06-28-2022	03-31-2022	10-K
10	02-14-2022	12-31-2021	10-Q
11	11-15-2021	09-30-2021	10-Q
12	09-21-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Evaluating Roivant Sciences: Insights From...
06/18/2024 15:00:13

Cantor Fitzgerald Reiterates Overweight on...
06/18/2024 14:07:26

Cantor Fitzgerald analyst Louise Chen reiterates Roivant Sciences (NASDAQ:ROIV) with a Overweight.

The Analyst Verdict: Roivant Sciences In T...
05/31/2024 14:00:16

HC Wainwright & Co. Reiterates Buy on Roiv...
05/31/2024 10:38:57

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

Roivant Sciences Q4 2024 GAAP EPS $(0.19) ...
05/30/2024 11:02:13

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0....

vivek-ramaswamy-breathes-new-life-into-beaten-down-buzzfeed-stock-whats-going-on

Vivek Ramaswamy Breathes New Life Into Bea...
05/22/2024 12:04:01

BuzzFeed shares surged after Vivek Ramaswamy acquired a 7.7% stake for $3.2 million.

Roivant And Kinevant Sciences Complete Enr...
04/25/2024 12:08:24

Critical Insights From Roivant Sciences An...
04/22/2024 15:01:12

HC Wainwright & Co. Reiterates Buy on Roiv...
04/22/2024 10:34:04

HC Wainwright & Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $18 price ta...

Goldman Sachs Maintains Buy on Roivant Sci...
04/03/2024 15:18:11

Goldman Sachs analyst Corinne Jenkins maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $...

HC Wainwright & Co. Maintains Buy on Roiva...
04/03/2024 11:05:41

HC Wainwright & Co. analyst Douglas Tsao maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target...

Deutsche Bank Maintains Buy on Roivant Sci...
04/03/2024 09:14:44

Deutsche Bank analyst Neena Bitritto-Garg maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target fr...

vivek-ramaswamy-founded-roivants-anti-inflammatory-drug-aces-mid-stage-study

Vivek Ramaswamy-Founded Roivant's Anti-Inf...
04/02/2024 16:31:51

Roivant Sciences and Priovant Therapeutics report Phase 2 results for brepocitinib in treating non-anterior non-infectious uvei...

Roivant Sciences Reveals Board Authorizati...
04/02/2024 11:12:00

Sumitomo Pharma repurchase reduces shares outstanding by 9%

Roivant Announces Positive NEPTUNE Study R...
04/02/2024 11:10:22

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
03/29/2024 17:35:25

Roivant Sciences To Replace Sunrun In S&P ...
03/26/2024 21:20:46

Where Roivant Sciences Stands With Analysts
03/25/2024 17:00:27

Truist Securities Reiterates Buy on Roivan...
03/25/2024 16:14:34

Truist Securities analyst Robyn Karnauskas reiterates Roivant Sciences (NASDAQ:ROIV) with a Buy and maintains $23 price target.

5 Value Stocks In The Healthcare Sector
02/19/2024 14:42:59